by | PRNewswire Asia
Direct subsidiary Samsung Peptide AG acting as formal offeror of the public tender offer Publication of offer prospectus follows pre-announcement on July 20, 2026 Largest individual shareholder committed to tender all of its PolyPeptide shares into offer Main offer...
by | PRNewswire Asia
Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for autologous stem cell transplant...
by | PRNewswire Asia
Third regulatory approval in less than six months enables food and beverage manufacturers to commercialize products sweetened with sweelin® in Israel. REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ — Amai Proteins announces that the Israeli Ministry of Health...
by | PRNewswire Asia
Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes. – Picture is available at...
by | PRNewswire Asia
BEIJING, Aug. 30, 2026 /PRNewswire/ — This year, the 47th Bangkok International Motor Show was held at the IMPACT Arena, Exhibition and Convention Center. BYD’s booth was packed, with crowds lining up to check out the vehicles on display. Increasingly,...
by | PRNewswire Asia
HONG KONG, Aug. 30, 2026 /PRNewswire/ — PetroChina Company Limited ["PetroChina" or the "Company", (HKSE: 00857; SSE: 601857)] announced that in the first half of 2026, the Company proactively responded to changes in the international...